Merck & Co., Inc. (MRK)
145.19
-2.18
(-1.48%)
USD |
NYSE |
Oct 15, 16:00
146.12
+0.92
(+0.64%)
Pre-Market: 07:32
Merck SG&A Expense (TTM) : 11.14B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.14B |
| March 31, 2026 | 10.88B |
| December 31, 2025 | 10.73B |
| September 30, 2025 | 10.70B |
| June 30, 2025 | 10.80B |
| March 31, 2025 | 10.89B |
| December 31, 2024 | 10.82B |
| September 30, 2024 | 10.76B |
| June 30, 2024 | 10.54B |
| March 31, 2024 | 10.51B |
| December 31, 2023 | 10.50B |
| September 30, 2023 | 10.39B |
| June 30, 2023 | 10.39B |
| March 31, 2023 | 10.20B |
| December 31, 2022 | 10.04B |
| September 30, 2022 | 10.18B |
| June 30, 2022 | 10.00B |
| March 31, 2022 | 9.77B |
| December 31, 2021 | 9.634B |
| September 30, 2021 | 9.423B |
| June 30, 2021 | 9.147B |
| March 31, 2021 | 8.951B |
| December 31, 2020 | 9.319B |
| September 30, 2020 | 9.588B |
| June 30, 2020 | 10.12B |
| Date | Value |
|---|---|
| March 31, 2020 | 10.74B |
| December 31, 2019 | 10.61B |
| September 30, 2019 | 10.37B |
| June 30, 2019 | 10.22B |
| March 31, 2019 | 10.02B |
| December 31, 2018 | 10.10B |
| September 30, 2018 | 10.10B |
| June 30, 2018 | 10.12B |
| March 31, 2018 | 10.11B |
| December 31, 2017 | 10.01B |
| September 30, 2017 | 9.963B |
| June 30, 2017 | 9.897B |
| March 31, 2017 | 9.855B |
| December 31, 2016 | 9.762B |
| September 30, 2016 | 9.784B |
| June 30, 2016 | 9.863B |
| March 31, 2016 | 10.03B |
| December 31, 2015 | 10.31B |
| September 30, 2015 | 10.62B |
| June 30, 2015 | 11.12B |
| March 31, 2015 | 11.47B |
| December 31, 2014 | 11.61B |
| September 30, 2014 | 11.66B |
| June 30, 2014 | 11.49B |
| March 31, 2014 | 11.66B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 19.22B |
| Eli Lilly & Co. | 12.24B |
| Pfizer Inc. | 13.72B |
| Bristol Myers Squibb Co. | 7.413B |
| Viatris, Inc. | 3.981B |